Zoetis, USDA and bird flu vaccine
Zoetis Receives Conditional License from USDA for Avian Influenza Vaccine, H5N2 Subtype, Killed Virus
Zoetis today announced that the U.S. Department of Agriculture (USDA), Center for Veterinary Biologics (CVB) has issued the company a conditional license for its Avian Influenza Vaccine, H5N2 Subtype,
commonly known as avian influenza. With growing concerns over the virus’s potential impact on public health, ICMR has begun the process of developing a vaccine for human use. The organization ...
Inc. (NYSE American: AIM) has announced its intention to develop Ampligen as a vaccine adjuvant for avian influenza. This ...
planning to switch to Trivalent Inactivated Influenza Vaccines (TIV) come September this year,” Dzulkefly told The Star. The TIV protects against three different strains of the flu virus.
H5N1 is one of many influenza ... vaccines are in the process of being updated to better match the strains currently circulating, according to Schaffner. Researchers are closely tracking avian ...
AIM ImmunoTech Inc. announced plans to advance its drug Ampligen as a vaccine adjuvant for avian ... A against highly pathogenic avian influenza virus strains H5N1, H7N9 and H7N3.
The Indian Council of Medical Research (ICMR) has begun the process of development of a vaccine against the deadly and highly-pathogenic H5N1 virus, also called avian influenza. ICMR will ...
manufacturers for joint collaboration in research and development for development of human vaccine candidate against H5N1. The avian influenza H5N1, a highly pathogenic strain of bird flu ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback